Cerebrovascular permeability changes during experimental meningitis in the rat

Area of Science:

• Neuroscience
• Pharmacokinetics
• Pathophysiology

Background:

• Bacterial meningitis disrupts the blood-brain and blood-cerebrospinal fluid barriers.
• Increased barrier permeability during meningitis is linked to adverse neurological outcomes.
• Understanding these alterations is crucial for developing effective treatments.

Purpose of the Study:

• To pharmacokinetically characterize cerebrovascular permeability changes during experimental bacterial meningitis.
• To quantify the impact of lipopolysaccharides on blood-brain barrier integrity.

Main Methods:

• Experimental meningitis induced via intracisternal lipopolysaccharide injection.
• 14C-sucrose used as a tracer to measure cerebrovascular integrity.
• Calculation of 14C-sucrose influx transfer coefficients (Kin(app)) and cerebrovascular volumes (Vbr) in brain regions.

Main Results:

• Lipopolysaccharide administration did not alter regional cerebrovascular volumes (Vbr).
• Significant increases (1.6- to 3.3-fold) in 14C-sucrose influx transfer coefficients (Kin(app)) were observed in multiple brain regions.
• Systemic pharmacokinetics of 14C-sucrose remained unaffected, ruling out systemic effects.

Conclusions:

• Experimental meningitis significantly increases cerebrovascular permeability in a dose-dependent manner.
• The observed permeability alterations are specific to the brain barriers and not due to systemic drug distribution changes.
• This methodology provides a framework for future studies on inflammatory mediators affecting cerebrovascular permeability.